Hybio Pharma Surges 20% After Announcing RWA Token Partnership with KuCoin

TradingKey

AuthorBlock Tao

Aug 4, 2025 6:06 AM

View all comments（0）



TradingKey – On Monday, August 4, Chinese pharmaceutical firm Hybio Pharma (SHE: 300199) saw its stock skyrocket 20% intraday, hitting the daily limit before settling around +18%, following news of a strategic partnership with KuCoin, the world’s 9th-largest crypto exchange.

altText

Hybio Pharma Stock Chart – Source: Google

Hybio and KuCoin will co-launch a Real World Asset (RWA) tokenization pilot, focused on the future revenue rights of Hybio’s GLP-1 peptide drug pipeline.

The token will be backed by Hybio’s proprietary R&D assets, including FDA-approved formulations and next-gen triple receptor agonists
KuCoin will provide full-stack support: blockchain infrastructure, token issuance, on-chain revenue mapping, and global compliance

This marks China’s first pharmaceutical RWA pilot, aligning with Hong Kong’s evolving virtual asset regulations.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Bitcoin Drops Below $70,000, May Log Sixth Straight Weekly Loss, Risking Slide Toward $65,000

TradingKey - As of the Asian trading session on November 13, Bitcoin (BTC) extended its decline, briefly falling below $70,000 intraday to reach a low of $69,150, marking a nearly three-month low. Higher-than-expected U.S. inflation data, rising expectations of a December Federal Reserve rate hike, and persistent net outflows from spot Bitcoin ETFs have collectively constituted the primary headwinds facing the cryptocurrency market recently.

Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?

TradingKey - As of the Asian session on Friday (November 13), gold prices (XAUUSD) rebounded intraday following a sharp drop on Thursday, with the latest price trading near $3,910. On Thursday, gold tumbled 2.76% to close at $3,877.41, confirming a breakdown below the $3,900 mark and touching a low of $3,852.27, hitting a fresh nearly one-year low. The decline in gold was primarily driven by renewed Middle East tensions pushing up international oil prices, coupled with persistently elevated U.S. inflationary pressures, which continue to weigh on gold's short-term trajectory.

SpaceX, Tesla Merger Reportedly Could Be Announced as Soon as December, Potentially Ahead of Democrats Taking Control of Congress in January

According to Bloomberg, citing people familiar with the matter, merger talks between SpaceX (SPCX) and Tesla (TSLA) have progressed, with a deal potentially being announced as early as December, though an option to delay the announcement until early 2027 has also been discussed. Boards and advisors from both companies are currently in discussions regarding transaction terms, the combined company's governance structure, and other matters.

Cisco Stock Retests $101.60 Ahead of Q1 Results, With AI Orders in Focus

TradingKey - CSCO rose 2.66% to $100.76 and now retests $101.60, the support it lost in early November, as Q1 results after the close put AI orders and margins in focus.

US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?

TradingKey - On Friday (November 13) Eastern Time, the U.S. will release the October Producer Price Index (PPI). Following October's CPI once again exceeding expectations, the market will look to the PPI to further assess whether price pressures on the U.S. production side are spreading, as well as the likelihood of the Federal Reserve raising interest rates by 25 basis points or 50 basis points in December.

Featured Tools